EPOLADERM
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Jun 2023)
What this means for you
This application is over — abandoned 26 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88692677
- Mark type
- Stylized text
- Filed
- 14 Nov 2019
- Published for opposition
- 31 Mar 2020
- Abandoned
- 26 Jun 2023
- Attorney of record
- G Kenneth Smith
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use containing diclofenac for the local treatment of the painful and inflammatory states of a rheumatic or traumatic nature
Owner
- Virpax Pharmaceuticals Inc., Malvern, PA, US
- Virpax Pharmaceuticals Inc., Malvern, PA, US
Prosecution history
- 26 Jun 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Jun 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2022 — SOU EXTENSION 5 GRANTED
- 28 Nov 2022 — SOU EXTENSION 5 FILED
- 02 Dec 2022 — NOTICE OF REVIVAL - E-MAILED
- 02 Dec 2022 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 02 Dec 2022 — PETITION TO REVIVE-GRANTED
- 02 Dec 2022 — TEAS PETITION TO REVIVE RECEIVED
- 27 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 May 2022 — SOU EXTENSION 4 GRANTED
- 25 May 2022 — SOU EXTENSION 4 FILED
- 25 May 2022 — SOU TEAS EXTENSION RECEIVED
- 08 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Dec 2021 — SOU EXTENSION 3 GRANTED